BerGenBio ASA (LON:0RU5)

BerGenBio ASA Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 18, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	25	58	56	150	240	128
Market Cap Growth	28.99%	3.72%	-62.90%	-37.37%	87.97%	-3.41%
Enterprise Value	13	45	37	108	174	103
Last Close Price	0.63	2.16	7.11	19.16	31.36	15.14
PS Ratio	758.49	2111.46	1702.55	2317.66	4675.15	167.10
PB Ratio	2.58	5.86	7.48	4.67	4.19	6.77
P/TBV Ratio	2.58	5.86	7.48	4.67	4.19	6.77
EV/Sales Ratio	374.38	1633.45	1123.96	1660.83	3380.88	134.58
Debt / Equity Ratio	-	0.00	0.00	0.00	0.00	0.00
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.03
Quick Ratio	4.58	3.55	2.12	6.91	11.04	5.31
Current Ratio	4.71	3.71	2.14	6.92	11.05	5.32
Return on Equity (ROE)	-96.83%	-176.32%	-127.77%	-58.67%	-57.76%	-71.55%
Return on Assets (ROA)	-52.66%	-70.31%	-61.93%	-33.08%	-32.36%	-39.35%
Return on Capital (ROIC)	-64.06%	-110.66%	-80.46%	-37.14%	-36.56%	-45.81%
Earnings Yield	-43.04%	-25.47%	-45.62%	-17.25%	-9.15%	-13.40%
FCF Yield	-35.17%	-30.12%	-43.52%	-16.91%	-8.34%	-12.55%
Buyback Yield / Dilution	-306.33%	-1514.80%	-0.77%	-17.40%	-29.10%	-8.91%
Total Shareholder Return	-306.33%	-1514.80%	-0.77%	-17.40%	-29.10%	-8.91%

Source: S&P Capital IQ. Standard template. Financial Sources.